chr3-49890602-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_002447.4(MST1R):c.3693C>T(p.Arg1231Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000512 in 1,614,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00029 ( 0 hom. )
Consequence
MST1R
NM_002447.4 synonymous
NM_002447.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.09
Genes affected
MST1R (HGNC:7381): (macrophage stimulating 1 receptor) This gene encodes a cell surface receptor for macrophage-stimulating protein (MSP) with tyrosine kinase activity. The mature form of this protein is a heterodimer of disulfide-linked alpha and beta subunits, generated by proteolytic cleavage of a single-chain precursor. The beta subunit undergoes tyrosine phosphorylation upon stimulation by MSP. This protein is expressed on the ciliated epithelia of the mucociliary transport apparatus of the lung, and together with MSP, thought to be involved in host defense. Alternative splicing generates multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.017).
BP6
Variant 3-49890602-G-A is Benign according to our data. Variant chr3-49890602-G-A is described in ClinVar as [Benign]. Clinvar id is 727440.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-4.09 with no splicing effect.
BS2
High AC in GnomAd4 at 406 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00265 AC: 404AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
404
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000749 AC: 188AN: 250990 AF XY: 0.000575 show subpopulations
GnomAD2 exomes
AF:
AC:
188
AN:
250990
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000288 AC: 421AN: 1461716Hom.: 0 Cov.: 31 AF XY: 0.000252 AC XY: 183AN XY: 727142 show subpopulations
GnomAD4 exome
AF:
AC:
421
AN:
1461716
Hom.:
Cov.:
31
AF XY:
AC XY:
183
AN XY:
727142
Gnomad4 AFR exome
AF:
AC:
320
AN:
33478
Gnomad4 AMR exome
AF:
AC:
30
AN:
44710
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26130
Gnomad4 EAS exome
AF:
AC:
4
AN:
39698
Gnomad4 SAS exome
AF:
AC:
3
AN:
86250
Gnomad4 FIN exome
AF:
AC:
1
AN:
53418
Gnomad4 NFE exome
AF:
AC:
21
AN:
1111886
Gnomad4 Remaining exome
AF:
AC:
38
AN:
60386
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00267 AC: 406AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.00235 AC XY: 175AN XY: 74484 show subpopulations
GnomAD4 genome
AF:
AC:
406
AN:
152324
Hom.:
Cov.:
32
AF XY:
AC XY:
175
AN XY:
74484
Gnomad4 AFR
AF:
AC:
0.00933231
AN:
0.00933231
Gnomad4 AMR
AF:
AC:
0.000849562
AN:
0.000849562
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0.000188324
AN:
0.000188324
Gnomad4 NFE
AF:
AC:
0
AN:
0
Gnomad4 OTH
AF:
AC:
0.00141777
AN:
0.00141777
Heterozygous variant carriers
0
23
46
69
92
115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at